Medical device for administering anti-IL-23 antibodies
US11939375B2 · kind B2 · utility
0Cited by
24References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2021 |
| Grant date | Mar 26, 2024 |
| Priority date | — |
| Expiry date | Jul 1, 2042 |
Classification
- Technology area (CPC —)General
Abstract
A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.